• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估和提高新生儿筛查经济评价方法学质量的具体指南。

Specific guidelines for assessing and improving the methodological quality of economic evaluations of newborn screening.

机构信息

Institute of Health Economics and Health Care Management, Munich School of Management, Ludwig-Maximilians Universität München, Munich, Germany.

出版信息

BMC Health Serv Res. 2012 Sep 4;12:300. doi: 10.1186/1472-6963-12-300.

DOI:10.1186/1472-6963-12-300
PMID:22947299
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3459803/
Abstract

BACKGROUND

Economic evaluation of newborn screening poses specific methodological challenges. Amongst others, these challenges refer to the use of quality adjusted life years (QALYs) in newborns, and which costs and outcomes need to be considered in a full evaluation of newborn screening programmes. Because of the increasing scale and scope of such programmes, a better understanding of the methods of high-quality economic evaluations may be crucial for both producers/authors and consumers/reviewers of newborn screening-related economic evaluations. The aim of this study was therefore to develop specific guidelines designed to assess and improve the methodological quality of economic evaluations in newborn screening.

METHODS

To develop the guidelines, existing guidelines for assessing the quality of economic evaluations were identified through a literature search, and were reviewed and consolidated using a deductive iterative approach. In a subsequent test phase, these guidelines were applied to various economic evaluations which acted as case studies.

RESULTS

The guidelines for assessing and improving the methodological quality of economic evaluations in newborn screening are organized into 11 categories: "bibliographic details", "study question and design", "modelling", "health outcomes", "costs", "discounting", "presentation of results", "sensitivity analyses", "discussion", "conclusions", and "commentary".

CONCLUSIONS

The application of the guidelines highlights important issues regarding newborn screening-related economic evaluations, and underscores the need for such issues to be afforded greater consideration in future economic evaluations. The variety in methodological quality detected by this study reveals the need for specific guidelines on the appropriate methods for conducting sound economic evaluations in newborn screening.

摘要

背景

新生儿筛查的经济评估带来了特定的方法学挑战。其中包括在新生儿中使用质量调整生命年(QALYs),以及在全面评估新生儿筛查计划时需要考虑哪些成本和结果。由于这些计划的规模和范围不断扩大,对于新生儿筛查相关经济评估的生产者/作者和消费者/审查者来说,更好地理解高质量经济评估方法可能至关重要。因此,本研究的目的是制定专门的指南,旨在评估和提高新生儿筛查中经济评估的方法学质量。

方法

为了制定指南,通过文献检索确定了评估经济评估质量的现有指南,并使用演绎迭代方法对其进行了审查和整合。在随后的测试阶段,将这些指南应用于各种作为案例研究的经济评估中。

结果

新生儿筛查中经济评估方法学质量评估和提高指南分为 11 类:“文献详情”、“研究问题和设计”、“建模”、“健康结果”、“成本”、“贴现”、“结果呈现”、“敏感性分析”、“讨论”、“结论”和“评论”。

结论

指南的应用突出了与新生儿筛查相关的经济评估中的重要问题,并强调需要在未来的经济评估中更加关注这些问题。本研究检测到的方法学质量的多样性表明,需要针对新生儿筛查中进行合理经济评估的适当方法制定具体指南。

相似文献

1
Specific guidelines for assessing and improving the methodological quality of economic evaluations of newborn screening.评估和提高新生儿筛查经济评价方法学质量的具体指南。
BMC Health Serv Res. 2012 Sep 4;12:300. doi: 10.1186/1472-6963-12-300.
2
A primer on economic evaluations related to expansion of newborn screening for genetic and metabolic disorders.关于与扩大遗传性和代谢性疾病新生儿筛查相关的经济评估入门指南。
J Obstet Gynecol Neonatal Nurs. 2006 Nov-Dec;35(6):692-9. doi: 10.1111/j.1552-6909.2006.00098.x.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
Recent economic evaluations of antenatal screening: a systematic review and critique.近期产前筛查的经济学评估:系统评价与批判
J Med Screen. 2000;7(2):59-73. doi: 10.1136/jms.7.2.59.
5
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
6
The Methodological Quality and Challenges in Conducting Economic Evaluations of Newborn Screening: A Scoping Review.新生儿筛查经济评估的方法学质量与挑战:一项范围综述
Int J Neonatal Screen. 2020 Nov 23;6(4):94. doi: 10.3390/ijns6040094.
7
Genetic screening by DNA technology: a systematic review of health economic evidence.通过DNA技术进行基因筛查:健康经济学证据的系统综述
Int J Technol Assess Health Care. 2006 Summer;22(3):327-37. doi: 10.1017/s0266462306051221.
8
Cost-Effectiveness Methods and Newborn Screening Assessment.成本效益分析方法与新生儿筛查评估。
Adv Exp Med Biol. 2017;1031:267-281. doi: 10.1007/978-3-319-67144-4_16.
9
The Use of Economic Evaluation to Inform Newborn Screening Policy Decisions: The Washington State Experience.运用经济评估为新生儿筛查政策决策提供信息:华盛顿州的经验
Milbank Q. 2016 Jun;94(2):366-91. doi: 10.1111/1468-0009.12196.
10
[Expert consensus on the follow-up of newborn screening for neonatal genetic and metabolic diseases].[新生儿遗传代谢病筛查随访专家共识]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2020 Apr 10;37(4):367-372. doi: 10.3760/cma.j.issn.1003-9406.2020.04.002.

引用本文的文献

1
Benefits and harms of antenatal and newborn screening programmes in health economic assessments: the VALENTIA systematic review and qualitative investigation.产前和新生儿筛查计划在健康经济评估中的获益和危害:VALENTIA 系统评价和定性研究。
Health Technol Assess. 2024 Jun;28(25):1-180. doi: 10.3310/PYTK6591.
2
Policy-making and implementation for newborn bloodspot screening in Europe: a comparison between EURORDIS principles and UK practice.欧洲新生儿血斑筛查的政策制定与实施:EURORDIS原则与英国实践的比较
Lancet Reg Health Eur. 2023 Aug 10;33:100714. doi: 10.1016/j.lanepe.2023.100714. eCollection 2023 Oct.
3
Benefits and harms adopted by health economic assessments evaluating antenatal and newborn screening programmes in OECD countries: A systematic review of 336 articles and reports.经合组织国家产前和新生儿筛查计划的健康经济评估所采用的效益和危害:对 336 篇文章和报告的系统评价。
Soc Sci Med. 2022 Dec;314:115428. doi: 10.1016/j.socscimed.2022.115428. Epub 2022 Oct 10.
4
An Economic Evaluation of Australia's Newborn Hearing Screening Program: A Within-Study Cost-Effectiveness Analysis.澳大利亚新生儿听力筛查计划的经济评价:一项基于研究的成本效益分析。
Ear Hear. 2022 May/Jun;43(3):972-983. doi: 10.1097/AUD.0000000000001153.
5
The Methodological Quality and Challenges in Conducting Economic Evaluations of Newborn Screening: A Scoping Review.新生儿筛查经济评估的方法学质量与挑战:一项范围综述
Int J Neonatal Screen. 2020 Nov 23;6(4):94. doi: 10.3390/ijns6040094.
6
Bioaerosol impact on crop health over India due to emerging fungal diseases (EFDs): an important missing link.生物气溶胶对印度作物健康的影响:新兴真菌病(EFDs)这一重要缺失环节。
Environ Sci Pollut Res Int. 2020 Apr;27(11):12802-12829. doi: 10.1007/s11356-020-08059-x. Epub 2020 Mar 2.
7
Iron deficiency screening for children at 18 months: a cost-utility analysis.18个月儿童缺铁筛查:成本效用分析
CMAJ Open. 2019 Dec 3;7(4):E689-E698. doi: 10.9778/cmajo.20190084. Print 2019 Oct-Dec.
8
Economic Evaluations of Childhood Hearing Loss Screening Programmes: A Systematic Review and Critique.儿童听力损失筛查计划的经济评价:系统评价和批判。
Appl Health Econ Health Policy. 2019 Jun;17(3):331-357. doi: 10.1007/s40258-018-00456-1.
9
Economic impact of screening for X-linked Adrenoleukodystrophy within a newborn blood spot screening programme.新生儿足跟血筛查项目中 X 连锁肾上腺脑白质营养不良的经济影响。
Orphanet J Rare Dis. 2018 Oct 11;13(1):179. doi: 10.1186/s13023-018-0921-4.
10
What Contribution Did Economic Evidence Make to the Adoption of Universal Newborn Hearing Screening Policies in the United States?经济证据对美国普遍新生儿听力筛查政策的采用有何贡献?
Int J Neonatal Screen. 2018;4(3):25. doi: 10.3390/ijns4030025. Epub 2018 Jul 20.

本文引用的文献

1
Decision analysis, economic evaluation, and newborn screening: challenges and opportunities.决策分析、经济评估与新生儿筛查:挑战与机遇
Genet Med. 2013;14(8):703-712. doi: 10.1038/gim.2012.24. Epub 2012 Apr 5.
2
Application of classic utilities to published pediatric cost-utility studies.经典效用方法在已发表的儿科成本效用研究中的应用。
Acad Pediatr. 2012 May-Jun;12(3):219-28. doi: 10.1016/j.acap.2011.09.003. Epub 2011 Nov 10.
3
Health economic analysis of screening.筛查的卫生经济学分析
GMS Curr Top Otorhinolaryngol Head Neck Surg. 2008;7:Doc01. Epub 2010 Oct 7.
4
Challenges in health state valuation in paediatric economic evaluation: are QALYs contraindicated?儿科经济评价中健康状态估值的挑战:QALYs 是否被禁止?
Pharmacoeconomics. 2011 Aug;29(8):641-52. doi: 10.2165/11591570-000000000-00000.
5
Screening of the hearing of newborns - Update.新生儿听力筛查——最新进展
GMS Health Technol Assess. 2006 Nov 27;2:Doc20.
6
Standardizing the inclusion of indirect medical costs in economic evaluations.标准化经济评估中间接医疗成本的纳入。
Pharmacoeconomics. 2011 Mar;29(3):175-87. doi: 10.2165/11586130-000000000-00000.
7
Towards a social discount rate for the economic evaluation of health technologies in Germany: an exploratory analysis.迈向德国卫生技术经济评估中的社会贴现率:探索性分析。
Eur J Health Econ. 2012 Apr;13(2):127-44. doi: 10.1007/s10198-010-0292-9. Epub 2010 Dec 19.
8
Discounting and decision making in the economic evaluation of health-care technologies.医疗保健技术经济评估中的折扣和决策。
Health Econ. 2011 Jan;20(1):2-15. doi: 10.1002/hec.1612. Epub 2010 May 12.
9
QALY weights for neurosensory impairments in pediatric economic evaluations: case studies and a critique.儿科经济评估中神经感觉损伤的 QALY 权重:案例研究与评价。
Expert Rev Pharmacoecon Outcomes Res. 2010 Jun;10(3):293-308. doi: 10.1586/erp.10.24.
10
Development of the EQ-5D-Y: a child-friendly version of the EQ-5D.EQ-5D-Y 的发展: EQ-5D 的儿童友好版本。
Qual Life Res. 2010 Aug;19(6):875-86. doi: 10.1007/s11136-010-9648-y. Epub 2010 Apr 20.